Medical Technologies, IPO and Kestra
Beta Bionics announced today that it went public after pricing a significantly upsized initial public offering (IPO).
MarketWatch on MSN13d
Obesity-drug maker Metsera posts largest gain as IPOs defy market swoonAt the closing bell, Metsera’s stock MTSR stood at $26.50, well above its IPO pricing level of $18. It opened on the Nasdaq ...
Companies are pushing ahead with their initial public offerings (IPOs) by compromising on valuations and reducing their issue ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results